atropineatropine-treatedpremyopialow myopiamyopia
…e were no significant differences in myopia progression between atropine and placebo treated eyes, there were trends towards less myopic…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 421–480 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
OCA8Daratumumab8TCE8Sunitinib8memantine8Calprotectin8Ribociclib8Dobutamine8sulfonylurea8Entinostat8Imatinib8Encorafenib8Rifapentine8SLEDAI8Canagliflozin8Dopamine8Maralixibat8Retatrutide8Bisoprolol8Daptomycin8Etanercept8DOAC8Parecoxib8Progesterone8chloroquine8Botulinum toxin8Quetiapine8Trastuzumab deruxtecan8high-intensity statin8local anaesthetic8Magnesium8mifepristone8GLP-18Albendazole8Hypertonic saline8PBS8Valproic acid8macrolides8Interleukin-68Mounjaro8Tylenol8Ursodeoxycholic acid (UDCA)8haloperidol8tenofovir alafenamide8NIVO7Bedaquiline7Glyburide7Nerandomilast7αPD-17Axi-Cel7Terlipressin7Butyrate75-ASA7IQOS7Ofatumumab7tPA7SGLT-2 Inhibitors7BsAb7Cladribine7Curcumin7
Articles mentioning drugs
10,506 articles · page 162 of 876adalimumabmethotrexatejuvenile idiopathic arthritisnon-infectious uveitisJIANIUtertiary UK centrespecialist paediatric rheumatology service
…ever, the development of neutralising antibodies may compromise adalimumab’s efficacy. This study investigated the incidence and clinical …
99.4%
inclisiranevolocumabalirocumabatorvastatinrosuvastatinperipheral arterial diseaseischaemic heart diseaseischaemic cerebrovascular diseaseheterozygous familial hypercholesterolaemiaHeFH+2 more
…itors (PCSK9 inhibitors), including evolocumab, alirocumab, and inclisiran, are potent lipid-lowering agents indicated for patients at hig…
atropine sulfateatropinemyopiaHospital pharmacy
….060 5.16 ± 0.012 Abstract 3PC-005 Tabel 3Average osmolality of atropine sulfate eye dropsBatch 4-week in use (mosm/kgH2O) 14-week stability (mo…
PipTazpiperacillin/tazobactamDepartment of Health and Social CarePharmacy Aseptic ServicesRegional GovernmentPharmacy Aseptic Services
…o administer (RTA) doses to Pharmacy Aseptic Services utilising PipTaz multidose bags.Aim and Objectives The aim of this research was …
OxaliplatinPaclitaxelFluorouracilrepetitive stress injuries
… container Withdrawal force (Kg) (SD) Insertion force (Kg) (SD) Oxaliplatin (100 mg/20 mL) 200 40 50 IV bag 4.22 (1.60) 5.80 (2.71) Oxalipl…
paclitaxelcarboplatincyclophosphamidefluorouracildoxorubicinKIRO-Oncologymusculoskeletal disorders
…). The drugs considered most difficult to prepare manually were paclitaxel (35%), fluorouracil (13%), and cyclophosphamide (12%), while th…
bosentandaratumumabazacitidineibrutinibnintedanibrare diseasesRDORPHANETnational health authorities
… (14.8%), nintedanib (11.3%), ibrutinib (10%), azacitidine, and bosentan (7.8%). OD distribution by ATC group was dominated by L (n=19),…
propranololmetoprololbisoprololhaemangiomasarterial hypertensionDivision of PaediatricsarrhythmiasATC group C07congenital malformations of the circulatory systemtachycardia
…d for use in children: metoprolol for arterial hypertension and propranolol for arrhythmias and haemangiomas. The use of these medications …
Inclisiranezetimibehypercholesterolaemiatertiary hospitalhypertriglyceridemia
… included (40% women; 60±7 years), all in secondary prevention. Inclisiran was indicated for failure to reach LDL-C targets despite optima…
argatrobanheparin-induced thrombocytopeniaICUHIThepatic dysfunctionExtracorporeal supportECMO
…e the impact of organ dysfunction and extracorporeal support on argatroban dosing requirements in critically ill patients.Material and Met…
99.3%
Pembrolizumablung cancermelanoma
…ced or metastatic disease, with 75% presenting brain metastases.Pembrolizumab discontinuation was due to disease progression (39%), immune-re…